SynteractHCR named Frank Santoro, M.D., who has more than 30 years of experience and most recently was Novella Clinical’s CMO, as its CMO.
DNA-encoded library technology expert HitGen just inked a multiyear, multitarget drug discovery deal with Aduro Biotech.
With pressures to fast-track clinical development, the pharmaceutical industry recognizes the value of improving internal clinical data management processes.…
Charles River Laboratories is buying CRO Brains On-Line for €18 million as it further strengthens its offers in CNS early-stage drug research.
WIRB-Copernicus Group has bought Patient Genesis’ eConsent technology, ConsentNow.
PRA will buy health data and analytics expert Symphony Health for $530 million up front as it reports 16% second-quarter service revenue growth.
Icon strengthens real-world evidence offerings by acquiring health research and commercialization company Mapi.
German CRO Evotec is acquiring U.S. counterpart Aptuit in a $300 million deal.
After months of rumors and amid a larger flurry of CRO M&A activity, LabCorp has bought out U.K. CRO Chiltern.
A BMJ paper has shown that progress is being made on clinical trial transparency, although there is still a way to go.
BeiGene is adding Medidata’s electronic patient-reported outcome solution to oncology clinical studies.